These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 81224
21. Infectious mononucleosis, Epstein-Barr virus, and chronic fatigue syndrome: a prospective case series. Fark AR. J Fam Pract; 1991 Feb; 32(2):202, 205-6, 209. PubMed ID: 1846641 [Abstract] [Full Text] [Related]
22. Recruitment during infectious mononucleosis of CD3+CD4+CD8+ virus-specific cytotoxic T cells which recognise Epstein-Barr virus lytic antigen BHRF1. White CA, Cross SM, Kurilla MG, Kerr BM, Schmidt C, Misko IS, Khanna R, Moss DJ. Virology; 1996 May 15; 219(2):489-92. PubMed ID: 8638417 [Abstract] [Full Text] [Related]
23. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia]. Okano M. Hokkaido Igaku Zasshi; 1986 Jul 15; 61(4):584-92. PubMed ID: 3019855 [Abstract] [Full Text] [Related]
25. [Epstein-Barr virus-specific immunity in asymptomatic carriers of human T-cell leukemia virus type 1]. Kwon KW. Hokkaido Igaku Zasshi; 1995 Mar 15; 70(2):315-28. PubMed ID: 7774883 [Abstract] [Full Text] [Related]
26. The disease associations of the antibody response against the Epstein-Barr virus transactivator protein ZEBRA can be separated into different epitopes. Tedeschi R, Foong YT, Cheng HM, dePaoli P, Lehtinen T, Elfborg T, Dillner J. J Gen Virol; 1995 Jun 15; 76 ( Pt 6)():1393-400. PubMed ID: 7540196 [Abstract] [Full Text] [Related]
27. Enhancement of Epstein-Barr virus antibody production in systemic lupus erythematosus patients. Stancek D, Robenský J. Acta Virol; 1979 Mar 15; 23(2):168-9. PubMed ID: 39442 [Abstract] [Full Text] [Related]
29. Cellular immunity in infectious mononucleosis: I. Spontaneous and phytohaemagglutinin-induced blast transformation in infectious mononucleosis, with special reference to depressed cellular reactivity and stimulation-blocking serum factors. Nikoskelainen J, Stevens DA, Neel EU, Isenberg RA, Miller RG, Halpern JW, Gelpi AP. IARC Sci Publ (1971); 1978 Mar 15; (24 Pt 2):699-709. PubMed ID: 751903 [Abstract] [Full Text] [Related]
30. Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition in infectious mononucleosis. II. Kinetics of sensitization against five EBV-encoded nuclear proteins and the latent membrane protein. Szigeti R, Kallin B, Dillner J, Henle G, Henle W, Lerner RA, Rymo L, Timar L, Klein G. Clin Immunol Immunopathol; 1989 Jun 15; 51(3):396-405. PubMed ID: 2470542 [Abstract] [Full Text] [Related]
31. Lymphocyte reactivity in infectious mononucleosis. ten Napel CH, The TH. J Infect Dis; 1980 Jun 15; 141(6):716-23. PubMed ID: 6248602 [Abstract] [Full Text] [Related]
32. IgA antibodies to Epstein-Barr virus in infectious mononucleosis. Marklund G, Henle W, Henle G, Ernberg I. Scand J Infect Dis; 1986 Jun 15; 18(2):111-9. PubMed ID: 3010447 [Abstract] [Full Text] [Related]
33. Epstein-Barr virus-specific serum immunoglobulin A as an acute-phase antibody in infectious mononucleosis. Nikoskelainen J, Neel EU, Stevens DA. J Clin Microbiol; 1979 Jul 15; 10(1):75-9. PubMed ID: 227922 [Abstract] [Full Text] [Related]
34. Epstein-Barr virus-carrying B cells in the blood during acute infectious mononucleosis give rise to lymphoblastoid lines in vitro by release of transforming virus and by proliferation. Lewin N, Aman P, Akerlund B, Gustavsson E, Carenfelt C, Lejdeborn L, Klein G, Klein E. Immunol Lett; 1990 Oct 15; 26(1):59-65. PubMed ID: 2177451 [Abstract] [Full Text] [Related]
35. Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection. Henle W, Henle G, Andersson J, Ernberg I, Klein G, Horwitz CA, Marklund G, Rymo L, Wellinder C, Straus SE. Proc Natl Acad Sci U S A; 1987 Jan 15; 84(2):570-4. PubMed ID: 3025881 [Abstract] [Full Text] [Related]
36. Cell-mediated immunity, Epstein-Barr virus and nasopharyngeal carcinoma. Levine PH, Lamelin JP, Stevens DA. IARC Sci Publ (1971); 1978 Jan 15; (20):483-94. PubMed ID: 215530 [Abstract] [Full Text] [Related]
37. Evaluation of enzyme-linked immunosorbent assays with two synthetic peptides of Epstein-Barr virus for diagnosis of infectious mononucleosis. Linde A, Kallin B, Dillner J, Andersson J, Jägdahl L, Lindvall A, Wahren B. J Infect Dis; 1990 May 15; 161(5):903-9. PubMed ID: 2157771 [Abstract] [Full Text] [Related]
38. Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition (LMI) in infectious mononucleosis (IM). I. Kinetics and response to a membrane protein on EBV-transformed cells. Szigeti R, Timar L, Weiland O, Henle W, Henle G, Hennessy K, Kieff E, Sulitzeanu D, Dillner J, Klein G. Clin Immunol Immunopathol; 1986 Dec 15; 41(3):342-50. PubMed ID: 3022972 [Abstract] [Full Text] [Related]
39. A human monoclonal autoantibody isolated from a patient with infectious mononucleosis reactive with both self antigens and Epstein-Barr virus nuclear antigen (EBNA). Garzelli C, Pacciardi A, Carmignani M, Conaldi G, Basolo F, Falcone G. Immunol Lett; 1989 Sep 15; 22(3):211-6. PubMed ID: 2478456 [Abstract] [Full Text] [Related]
40. [Role of the B lymphocytes in children with infectious mononucleosis caused by Epstein-Barr Virus]. Luo XM, Zhou FY, Zhou YL, Wang XX, Qiu LN. Zhonghua Er Ke Za Zhi; 2004 Sep 15; 42(9):701-4. PubMed ID: 15482676 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]